Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04457596
Brief Title: T-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High Risk HER2-Positive Breast Cancer, the CompassHER2 RD Trial

First Submitted : June 30, 2020
First Submitted that Met QC Criteria : June 30, 2020
First Posted : July 7, 2020

Last Update Submitted that Met QC Criteria : July 19, 2021
Last Update Posted : July 20, 2021